Mann JP, Savage DB. What lipodystrophies teach us about the metabolic syndrome. J Clin Invest. 2019;129:4009–21. https://doi.org/10.1172/JCI129190

Article  PubMed  PubMed Central  Google Scholar 

Lim K, Haider A, Adams C, Sleigh A, Savage DB. Lipodistrophy: a paradigm for understanding the consequences of “overloading” adipose tissue. Physiol Rev. 2021;101:907–93. https://doi.org/10.1152/physrev.00032.2020

Article  CAS  PubMed  Google Scholar 

Hussain I, Garg A. Lipodystrophy syndromes. Endocrinol Metab Clin North Am. 2016;45:783–97. https://doi.org/10.1016/j.ecl.2016.06.012

Article  PubMed  PubMed Central  Google Scholar 

Sollier C, Vatier C, Capel E, Lascols O, Auclair M, Janmaat S, et al. Lipodystrophic syndromes: from diagnosis to treatment. Ann Endocrinol. 2020;81:51–60. https://doi.org/10.1016/j.ando.2019.10.003

Article  Google Scholar 

Mosbah H, Vatier C, Vigouroux C. Partial lipodystrophy: clinical presentation and treatment. Ann Endocrinol (Paris). 2024;85:197–200. https://doi.org/10.1016/j.ando.2024.05.015

Article  PubMed  Google Scholar 

Robbins AL, Savage DB. The genetics of lipid storage and human lipodystrophies. Trends Mol Med. 2015;21:433–8. https://doi.org/10.1016/j.molmed.2015.04.004

Article  CAS  PubMed  Google Scholar 

Garg A. Clinical review#: lipodystrophies: genetic and acquired body fat disorders. J Clin Endocrinol Metab. 2011;96:3313–25. https://doi.org/10.1210/jc.2011-1159

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shimomura I, Hammer RE, Richardson JA, Ikemoto S, Bashmakov Y, Goldstein JL, et al. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev. 1998;12:3182–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moitra J, Mason MM, Olive M, Krylov D, Gavrilova O, Marcus-Samuels B, et al. Life without white fat: a transgenic mouse. Genes Dev. 1998;12:3168–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Linhart HG, Ishimura-Oka K, DeMayo F, Kibe T, Repka D, Poindexter B, et al. C/EBPalpha is required for differentiation of white, but not brown, adipose tissue. Proc Natl Acad Sci USA. 2001;98:12532–7. https://doi.org/10.1073/pnas.211416898

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shimomura I, Hammer RE, Ikemoto S, Brown MS, Goldstein JL. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature. 1999;401:73–6.

Article  CAS  PubMed  Google Scholar 

Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, et al. Leptin-replacement therapy for lipodystrophy. N. Engl J Med. 2002;346:570–8.

Article  CAS  PubMed  Google Scholar 

Petersen KF, Oral EA, Dufour S, Befroy D, Ariyan C, Yu C, et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest. 2002;109:1345–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vigouroux C, Mosbah H, Vatier C. Leptin replacement therapy in the management of lipodystrophy syndromes. Ann Endocrinol. 2024;85:201–4. https://doi.org/10.1016/j.ando.2024.05.022

Article  Google Scholar 

Gavrilova O, Marcus-Samuels B, Graham D, Kim JK, Shulman GI, Castle AL, et al. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest. 2000;105:271–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guénantin A-C, Briand N, Capel E, Dumont F, Morichon R, Provost C, et al. Functional human beige adipocytes from induced pluripotent stem cells. Diabetes. 2017;66:1470–8. https://doi.org/10.2337/db16-1107

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tiwari M, Roumane A, Sommer N, Han W, Delibegovic M, Rochford JJ, et al. Preclinical evaluation of tissue-selective gene therapies for congenital generalised lipodystrophy. Gene Ther. 2024;31:445–54. https://doi.org/10.1038/s41434-024-00471-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Magre J, Prieur X. Seipin deficiency as a model of severe adipocyte dysfunction: lessons from rodent models and teaching for human disease. Int J Mol Sci. 2022;23:740. https://doi.org/10.3390/ijms23020740

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sommer N, Roumane A, Han W, Delibegovic M, Rochford JJ, McIlroy GD. Gene therapy restores adipose tissue and metabolic health in a pre-clinical mouse model of lipodystrophy. Mol Ther Methods Clin Dev. 2022;27:206–16. https://doi.org/10.1016/j.omtm.2022.09.014

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bates R, Huang W, Cao L. Adipose tissue: an emerging target for adeno-associated viral vectors. Mol Ther Methods Clin Dev. 2020;19:236–49. https://doi.org/10.1016/j.omtm.2020.09.009

Article  CAS  PubMed  PubMed Central  Google Scholar 

Uhrig-Schmidt S, Geiger M, Luippold G, Birk G, Mennerich D, Neubauer H, et al. Gene delivery to adipose tissue using transcriptionally targeted rAAV8 vectors. PLoS One. 2014;9:e116288. https://doi.org/10.1371/journal.pone.0116288

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu, X, Magee, D, Wang, C, McMurphy, T, Slater, A, During, M, et al. (2014). Adipose tissue insulin receptor knockdown via a new primate-derived hybrid recombinant AAV serotype. Mol Ther Methods Clin Dev 1. https://doi.org/10.1038/mtm.2013.8.

Huang W, Liu X, Queen NJ, Cao L. Targeting visceral fat by intraperitoneal delivery of novel AAV serotype vector restricting off-target transduction in liver. Mol Ther Methods Clin Dev. 2017;6:68–78. https://doi.org/10.1016/j.omtm.2017.06.002

Article  CAS  PubMed  PubMed Central  Google Scholar 

Queen NJ, Bates R, Huang W, Xiao R, Appana B, Cao L. Visceral adipose tissue-directed FGF21 gene therapy improves metabolic and immune health in BTBR mice. Mol Ther Methods Clin Dev. 2021;20:409–22. https://doi.org/10.1016/j.omtm.2020.12.011

Article  CAS  PubMed  Google Scholar 

Xiao R, Mansour AG, Huang W, Chrislip LA, Wilkins RK, Queen NJ, et al. Adipocytes: a novel target for IL-15/IL-15Ralpha cancer gene therapy. Mol Ther. 2019;27:922–32. https://doi.org/10.1016/j.ymthe.2019.02.011

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morato L, Astori S, Zalachoras I, Rodrigues J, Ghosal S, Huang W, et al. eNAMPT actions through nucleus accumbens NAD(+)/SIRT1 link increased adiposity with sociability deficits programmed by peripuberty stress. Sci Adv. 2022;8:eabj9109 https://doi.org/10.1126/sciadv.abj9109

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wagner G, Fenzl A, Lindroos-Christensen J, Einwallner E, Husa J, Witzeneder N, et al. LMO3 reprograms visceral adipocyte metabolism during obesity. J Mol Med. 2021;99:1151–71. https://doi.org/10.1007/s00109-021-02089-9

Article  CAS  PubMed  Google Scholar 

Huang W, Bates R, Appana B, Mohammed T, Cao L. Development of an adipose-tropic AAV capsid ablating liver tropism. iScience. 2024. https://doi.org/10.1016/j.isci.2024.110930.

Klein S, Gastaldelli A, Yki-Jarvinen H, Scherer PE. Why does obesity cause diabetes? Cell Metab. 2022;34:11–20.